share_log

Agape ATP | 8-K: Current report

Agape ATP | 8-K: Current report

Agape ATP | 8-K:重大事件
美股SEC公告 ·  2024/09/30 21:13

Moomoo AI 已提取核心信息

Agape ATP Corporation has entered into a strategic collaboration with Formedic Technologies on September 25, 2024, to introduce LEGA, an electronic chest percussion device for respiratory care. The device, which has already been deployed in approximately 2,000 units across major hospitals globally, aids patients with COPD, pneumonia, and bronchiectasis in both hospital and home care settings.The partnership targets the expanding respiratory care market, projected to reach $25.95B in 2024 and grow to $49.84B by 2031. This collaboration enables ATPC to diversify its wellness portfolio while leveraging Formedic's healthcare technology expertise and R&D capabilities. The initiative aligns with ATPC's strategy to build a comprehensive wellness ecosystem encompassing both preventive and curative solutions.The companies will jointly develop marketing strategies to establish LEGA as a leading respiratory care solution, focusing on expanding its accessibility to hospitals, rehabilitation centers, and home users globally. The partnership also emphasizes ongoing R&D efforts to advance respiratory care innovations and improve patient outcomes.
Agape ATP Corporation has entered into a strategic collaboration with Formedic Technologies on September 25, 2024, to introduce LEGA, an electronic chest percussion device for respiratory care. The device, which has already been deployed in approximately 2,000 units across major hospitals globally, aids patients with COPD, pneumonia, and bronchiectasis in both hospital and home care settings.The partnership targets the expanding respiratory care market, projected to reach $25.95B in 2024 and grow to $49.84B by 2031. This collaboration enables ATPC to diversify its wellness portfolio while leveraging Formedic's healthcare technology expertise and R&D capabilities. The initiative aligns with ATPC's strategy to build a comprehensive wellness ecosystem encompassing both preventive and curative solutions.The companies will jointly develop marketing strategies to establish LEGA as a leading respiratory care solution, focusing on expanding its accessibility to hospitals, rehabilitation centers, and home users globally. The partnership also emphasizes ongoing R&D efforts to advance respiratory care innovations and improve patient outcomes.
Agape ATP公司于2024年9月25日与Formedic科技公司达成战略合作,引入LEGA,这是一款用于呼吸护理的电子胸部叩击设备。该设备已经在全球主要医院部署了大约2000台,帮助慢性阻塞性肺病、肺炎和支气管扩张症的患者在医院和家庭护理环境中进行治疗。此合作针对不断扩大的呼吸护理市场,预计到2024年市场将达到259.5亿,2031年将增长至498.4亿。此次合作使ATPC能够多样化其健康产品组合,同时利用Formedic的医疗科技专业知识和研发能力。该倡议与ATPC的策略一致,旨在建立一个全面的健康生态系统,涵盖预防和治疗方案。两家公司将共同制定市场策略,确立LEGA作为领先的呼吸护理解决方案,重点扩大其在全球医院、康复中心和家庭用户的可及性。该伙伴关系还强调了持续的研发工作,以推进呼吸护理创新并改善患者的治疗效果。
Agape ATP公司于2024年9月25日与Formedic科技公司达成战略合作,引入LEGA,这是一款用于呼吸护理的电子胸部叩击设备。该设备已经在全球主要医院部署了大约2000台,帮助慢性阻塞性肺病、肺炎和支气管扩张症的患者在医院和家庭护理环境中进行治疗。此合作针对不断扩大的呼吸护理市场,预计到2024年市场将达到259.5亿,2031年将增长至498.4亿。此次合作使ATPC能够多样化其健康产品组合,同时利用Formedic的医疗科技专业知识和研发能力。该倡议与ATPC的策略一致,旨在建立一个全面的健康生态系统,涵盖预防和治疗方案。两家公司将共同制定市场策略,确立LEGA作为领先的呼吸护理解决方案,重点扩大其在全球医院、康复中心和家庭用户的可及性。该伙伴关系还强调了持续的研发工作,以推进呼吸护理创新并改善患者的治疗效果。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息